UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
MEDICAL INDUSTRIES OF AMERICA, INC.
- -------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, NO PAR VALUE
- -------------------------------------------------------------------------------
(Title of Class of Securities)
58457T201
- -------------------------------------------------------------------------------
(CUSIP Number)
ALEXANDER V. GANCIA
ALEX. BROWN & SONS INCORPORATED
SUITE 1200, 222 LAKEVIEW AVENUE
WEST PALM BEACH, FL 33401
(561)832-4488
- -------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
JANUARY 20, 1997
- -------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
SCHEDULE 13D
CUSIP NO. 58457T201 Page 2 of 6 Pages
- --------------------------------------------------------------------------------
1. Name of reporting person
S.S. or I.R.S. Identification No. of above person
Alexander V. Gancia
Social Security #: Not Required
- --------------------------------------------------------------------------------
2. Check the appropriate box if a member of a group*
(a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3. SEC Use Only
- --------------------------------------------------------------------------------
4. Source of Funds* PF
- --------------------------------------------------------------------------------
5. Check Box if Disclosure of Legal Proceedings is
Required Pursuant to Items 2(d) or 2(E) [ ]
- --------------------------------------------------------------------------------
6. Citizenship or Place of Organization
Switzerland
- --------------------------------------------------------------------------------
Number of 7. Sole Voting Power
Shares 60,000
Beneficially 8. Shared Voting Power
Owned By 40,000
Each 9. Sole Dispositive Power
Reporting 60,000
Person With 10. Shared Dispositive Power
40,000
- --------------------------------------------------------------------------------
11. Aggregate Amount Beneficially Owned by Reporting Person
100,000
- --------------------------------------------------------------------------------
12. Check Box if the Aggregate Amount in Row (11) Excludes Certain
Shares* [ ]
- --------------------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row (11)
9.7%
- --------------------------------------------------------------------------------
14. Type of Reporting Person*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
2
<PAGE>
This Initial Statement on Schedule 13D, dated February 26, 1997, is filed
pursuant to Section 13D of the Securities Exchange Act of 1934, as
amended (the "Exchange Act"), by Alexander V. Gancia ("Gancia"). Gancia
is hereinafter referred to as the "Reporting Person."
ITEM 1. SECURITY AND ISSUER
This Schedule 13D relates to the Common Stock, no par value, (the "Common
Stock") of Medical Industries of America, Inc. (the "Company"). The
address of the principal executive offices of the Company is 1903 S.
Congress Avenue, Suite 400, Boynton Beach, Florida 33426.
ITEM 2. IDENTITY AND BACKGROUND.
(a) Name: Alexander V. Gancia
(b) Business Address of Gancia:
Alex. Brown & Sons Incorporated
Suite 1200, 222 Lakeview Avenue
West Palm Beach, FL 33401
(c) Occupation of Gancia: Investment Representative
Name, principal business and address of any corporation or
organization in which such employment is conducted:
Alex. Brown & Sons Incorporated
Suite 1200, 222 Lakeview Avenue
West Palm Beach, FL 33401
(d) and (e)
During the last five years, the Reporting Person has not been convicted
in a criminal proceeding (excluding traffic violations and other minor
offenses), nor been a party to a civil proceeding of a judicial or
administrative body of competent jurisdiction and as a result of such
proceeding was or is subject to a judgment, decree or final order
enjoining future violations of, or prohibiting or mandating activities
subject to, federal or state securities laws or finding any violations
with respect to such laws.
(f) Citizenship of Reporting Person:
Switzerland
ITEM 3. SOURCE AND AMOUNT OF FUNDS.
3
<PAGE>
The 60,000 shares of Common Stock over which Gancia has sole voting and
dispositive power were acquired by purchase with Gancia's personal funds.
The 40,000 shares of Common Stock over which Gancia shares voting and
dispositive power with customers of Alex. Brown & Sons Incorporated
("Alex Brown") were acquired by purchase with personal funds of those
customers. Collectively, the 60,000 shares and 40,000 shares are
hereinafter referred to as the "Shares." The Shares were acquired on the
dates and at the prices set forth in Schedule A.
ITEM 4. PURPOSE OF THE TRANSACTION.
The Shares will be held for investment purposes and not for the purpose
or in connection with any transaction having the purpose of changing the
control of the Company, and the Reporting Person has no present intention
to effect any of the transactions enumerated in clauses (a) through (j)
of Item 4 of Schedule 13D.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
As of the date hereof, the Reporting Person, by virtue of Rule 13d-3
under the Exchange Act, (a) has sole voting and dispositive power over
60,000 shares (approximately 5.8% of the total number of shares of Common
Stock outstanding as disclosed in the Form 10-Q for the quarter ended
September 30, 1996 of the Company, which is the most recently available
filing by the Company with the Securities and Exchange Commission (the
"10-Q")) and (b) may be deemed to share voting and dispositive power over
40,000 Shares (approximately 3.9% of the total number of shares of Common
Stock outstanding as disclosed in the 10-Q) which shares are held in the
accounts of customers of Alex Brown over which the Reporting Person has
investment discretion.
Pursuant to Rule 13d-4 promulgated under the Exchange Act, Gancia hereby
expressly states that the filing of this Schedule 13D shall not be
construed as an admission that Gancia is, for the purposes of Section
13(d) or 13(g) of the Exchange Act, the beneficial owner of the 40,000
Shares held in the accounts of the customers of Alex Brown.
Schedule A to this Statement lists all transactions in the Common Stock
of the Company that were effected by the Reporting Person during the
sixty days preceding the date hereof.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH
RESPECT TO SECURITIES OF THE ISSUER.
Other than as disclosed herein, the Reporting Person is not a party to
any contracts, arrangement, understandings or relationships (legal or
otherwise) with any person with respect to any securities of the Company,
including, but not limited to, transfer or voting of any such securities,
finder's fees, joint ventures, loan or option arrangements, put or calls,
guarantees of profits, division of profits or loss, or the giving or
withholding of proxies.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
None.
4
<PAGE>
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: February 26, 1997 /s/ ALEXANDER V. GANCIA
-------------------------
Alexander V. Gancia
5
<PAGE>
SCHEDULE A
PURCHASER TRANSACTION NUMBER OF SHARES TRADE DATE PRICE PER SHARE
--------- ----------- ---------------- ---------- ---------------
Gancia Purchase 10,000 2/7/97 $2.42
Purchase 20,000 1/27/97 1.50
Purchase 50,000 1/10/97 .50
Sale 20,000 1/23/97 1.60
Customers Purchase 10,000 2/10/97 2.51
Purchase 20,000 1/20/97 1.63
Purchase 10,000 2/5/97 3.38
- -----------------------------------
All purchases were effectuated in the open market.
6
